Latest News & Features
Americas
Gene-editing company CRISPR Therapeutics has partnered with regenerative medicine-focused ViaCyte to focus on diabetes treatments. 19 September 2018
Big Pharma
Researchers from three London universities and the Francis Crick Institute have joined together to form a hub for cancer biotherapeutics research and treatment, made possible by a £14 million investment from charity Cancer Research UK. 19 September 2018
Americas
The US Court of Appeals for the Federal Circuit yesterday overturned a Patent Trial and Appeal Board decision that had said chemical company DuPont hadn’t proved that a patent was invalid. 18 September 2018
Americas
Allergan has revealed plans to buy Bonti, a biotechnology company focused on medical aesthetics, for $195 million. 18 September 2018
Americas
A former GSK scientist has pleaded guilty to charges that he conspired to steal trade secrets to benefit a China-based company that he helped establish, according to the US Department of Justice. 17 September 2018
Big Pharma
The European Patent Office has upheld a patent covering Gilead’s hepatitis C medicine sofosbuvir, despite opposition from humanitarian organisation Médecins Sans Frontières. 17 September 2018
Europe
Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount. 14 September 2018
Big Pharma
Personalised healthcare is a rapidly developing field, not just because of medical advancements, but also because the criteria necessary to secure second medical use patents has similarly evolved over the years, an industry webinar heard. 13 September 2018
Americas
Boston-based Nutter McClennen & Fish has added a team of IP professionals: three partners, two of counsels, one associate, and one technical specialist. 13 September 2018
Americas
Canada-based Bausch Health has agreed to settle all IP litigation with Actavis over antibiotic drug Xifaxan (rifaximin). 13 September 2018